Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun 6;6(6):e739.
doi: 10.1097/HS9.0000000000000739. eCollection 2022 Jun.

The Use of Next-generation Sequencing in the Diagnosis of Rare Inherited Anaemias: A Joint BSH/EHA Good Practice Paper

Affiliations

The Use of Next-generation Sequencing in the Diagnosis of Rare Inherited Anaemias: A Joint BSH/EHA Good Practice Paper

Noémi B A Roy et al. Hemasphere. .
No abstract available

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
(A) Cartoon of the process of creating an NGS report from arrival of sample in the laboratory. (Usually includes clinical scientists and clinicians.) (B) American College of Medical Genetics variant classification, with examples of further studies that can be carried out to determine the pathogenicity of class 3 variants of uncertain significance. This includes family studies to investigate segregation, as well as functional assays such as red cell enzyme activities, EMA dye binding for hereditary spherocytosis, and osmotic gradient ektacytometry (Osmoscan), which investigates red cell deformability for membrane disorders. This list is not exhaustive and includes other functional assays (eg, electron microscopy for CDA, ribosomal profiling, or northern blots for DBA); EMA dye binding. CDA = congenital dyserythropoietic anaemias; DBA = Diamond-Blackfan anaemia; Ekta = ektacytometry; EMA = eosin-5’-maleimide; MDT = multidisciplinary team; NGS = next-generation sequencing.
Figure 2.
Figure 2.
Clinical and laboratory assessment of the patient with a suspected diagnosis of inherited anaemia. These are indicative only and not exhaustive. eADA, erythrocyte adenosine deaminase; EMA, eosin-5′-maleimide test; FBC, full blood count; HPLC, high performance liquid chromatography; LDH, lactate dehydrogenase; LFTs, liver function tests; retics, reticulocytes; U&Es, urea and electrolytes.

References

    1. Roy NB, Wilson EA, Henderson S, et al. . A novel 33-Gene targeted resequencing panel provides accurate, clinical-grade diagnosis and improves patient management for rare inherited anaemias. Br J Haematol. 2016;175:318–330. - PMC - PubMed
    1. Agarwal AM, Nussenzveig RH, Reading NS, et al. . Clinical utility of next-generation sequencing in the diagnosis of hereditary haemolytic anaemias. Br J Haematol. 2016;174:806–814. - PubMed
    1. He Y, Luo J, Lei Y, et al. . A novel PKLR gene mutation identified using advanced molecular techniques. Pediatr Transplant. 2018;22. - PubMed
    1. Mirabello L, Khincha PP, Ellis SR, et al. . Novel and known ribosomal causes of Diamond-Blackfan anaemia identified through comprehensive genomic characterisation. J Med Genet. 2017;54:417–425. - PubMed
    1. Hamada M, Doisaki S, Okuno Y, et al. . Whole-exome analysis to detect congenital hemolytic anemia mimicking congenital dyserythropoietic anemia. Int J Hematol. 2018;108:306–311. - PubMed